Klaus-Peter Ossenkopp Selected Research

Klaus-Peter Ossenkopp Research Topics

14	Nausea 12/2023 - 02/2007
6	Autism Spectrum Disorder 01/2020 - 01/2007
5	Body Weight (Weight, Body) 01/2017 - 02/2009
3	Acute-Phase Reaction 10/2018 - 05/2012
2	Infections 01/2023 - 01/2019
2	Weight Loss (Weight Reduction) 05/2012 - 01/2003
2	Breast Neoplasms (Breast Cancer) 09/2009 - 02/2009
2	Autistic Disorder (Autism) 06/2009 - 05/2008
1	Neurodevelopmental Disorders 12/2014
1	Obesity 02/2012
1	Neuroinflammatory Diseases 02/2011
1	Neoplasms (Cancer) 09/2009
1	Bacterial Infections (Bacterial Infection) 10/2007
1	Vomiting 02/2007
1	Seizures (Absence Seizure) 01/2007
1	Pain (Aches) 01/2007
1	Hyperphagia (Overeating) 05/2006

10	LipopolysaccharidesIBA 01/2023 - 01/2003
9	propionic acid (potassium propionate)IBA 01/2020 - 01/2007
6	Lithium ChlorideIBA 01/2023 - 09/2011
5	EndotoxinsIBA 12/2023 - 05/2012
3	Oxytocin (Pitocin)FDA LinkGeneric 01/2023 - 12/2016
3	Volatile Fatty AcidsIBA 01/2019 - 01/2007
3	Estradiol (Delestrogen)FDA LinkGeneric 10/2018 - 02/2009
2	SaccharinIBA 06/2012 - 09/2011
2	Acetylmuramyl-Alanyl-IsoglutamineIBA 05/2012 - 01/2003
2	SolutionsIBA 09/2011 - 05/2006
2	Estrogen ReceptorsIBA 09/2009 - 02/2009
2	Selective Estrogen Receptor Modulators (SERM)IBA 09/2009 - 02/2009
2	Tamoxifen FDA LinkGeneric 09/2009 - 02/2009
1	EmeticsIBA 10/2021
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2019
1	Poly I-CIBA 05/2012
1	CorticosteroneIBA 06/2011
1	Gastrointestinal AgentsIBA 02/2011
1	Raloxifene Hydrochloride (Evista)FDA Link 02/2009
1	Dopamine (Intropin)FDA LinkGeneric 10/2007
1	CannabinoidsIBA 02/2007
1	anandamide (arachidonylethanolamide)IBA 02/2007
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 02/2007
1	LithiumIBA 02/2007
1	Sucrose (Saccharose)IBA 05/2006
1	Pregnanolone (Allopregnanolone)IBA 05/2006

3	Injections 01/2017 - 06/2009
2	Drug Therapy (Chemotherapy) 12/2016 - 02/2008
1	Chemoprevention 02/2009
1	Intraventricular Infusions 01/2007
1	Analgesia 01/2007